Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.441.541.802.102.69

What is the latest Fixed Capital/Sales ratio of ORCHID PHARMA ?

The latest Fixed Capital/Sales ratio of ORCHID PHARMA is 1.44 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.44
Mar20241.54
Mar20231.80
Mar20222.10
Mar20212.69

How is Fixed Capital/Sales of ORCHID PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.44
-6.49
Mar2024 1.54
-14.44
Mar2023 1.8
-14.29
Mar2022 2.1
-21.93
Mar2021 2.69 -

Other Financial Ratios of ORCHID PHARMA


Compare Fixed Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,490.2 Cr 0.1% -11.8% -50.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

0.1%

-11.8%

-50.4%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses